
Academic Journal
Q1Frontiers in Drug Safety and Regulation
About Frontiers in Drug Safety and Regulation
Frontiers in Drug Safety and Regulation is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q1, with an SJR of 0.724 and H-index of 9.
Coverage: 2021-2026. Research categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Epidemiology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Pharmacovigilance and Adverse Drug Reactions; Health Systems, Economic Evaluations, Quality of Life; Biosimilars and Bioanalytical Methods; Pregnancy and Medication Impact; Drug-Induced Adverse Reactions; Computational Drug Discovery Methods.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Two decades of prescription opioid-related cardiovascular safety signals: a FAERS-based pharmacovigilance study using machine learning
Li Ma, Johnna Berryhill, John Ihrie, Ru Chen et al.
2026-09-28 · DOI: 10.3389/fdsfr.2026.1898403Global patterns and trends in spontaneous reporting systems: VigiBase, FAERS, VAERS, and JADER
Nikola Panajotovikj, Jordi Mestres
2026-09-04 · DOI: 10.3389/fdsfr.2026.1919822Oral absorption of high molecular weight polyethylene glycols: mechanistic, safety and regulatory insights
Chiara G. M. Gennari, Sara Azari, Antonella Casiraghi, Umberto M. Musazzi et al.
2026-08-28 · DOI: 10.3389/fdsfr.2026.1851318Psychotropic dispensing in Greek adolescents and young adults: national trends and regional variation
Konstantinos Kassandros, Maria Samakouri, Maria Panagopoulou, Theodoros Constantinidis et al.
2026-08-25 · DOI: 10.3389/fdsfr.2026.1900494Does generative AI mean the “end of history” for pharmacovigilance automation? towards a framework for the future of human-AI systems
Leihong Wu, Joshua Xu, Oanh Dang, Robert Ball et al.
2026-08-18 · DOI: 10.3389/fdsfr.2026.1846339InfoMedex: drug-drug interaction prediction via a multimodal CNN-transformer model
Andrew Disharoon, Shifi Pasupuleti, Clark Thurston, Matt Fiore et al.
2026-08-12 · DOI: 10.3389/fdsfr.2026.1841035Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence
Matija Sošić, Valentino Rački, Almir Fajkić, Mladen Jašić et al.
2026-08-12 · DOI: 10.3389/fdsfr.2026.1836444Topical retinoids and risk of major congenital malformations and spontaneous abortion: a systematic review and meta-analysis
Alaa Baqer Alali, Fatimah Ahmed Alhammad, Jumanah Ameer Almohammed Saleh, Salwa Baqer Alshaikh et al.
2026-07-23 · DOI: 10.3389/fdsfr.2026.1864872Safety profile of small interfering RNA therapeutics: a systematic review and meta-analysis of randomized controlled trials
Cheewon Ahn, Hyunsuk Jeong, Hyeon Woo Yim, Na Jin Kim et al.
2026-07-10 · DOI: 10.3389/fdsfr.2026.1855572Use of public health databases for the early identification of Autism spectrum disorder: a scoping review protocol
Luiz Jupiter Carneiro de Souza, Luis Phillipe Nagem Lopes, Mariana Del Grossi Moura, Katia Miyuki Sasaki Zeredo et al.
2026-06-16 · DOI: 10.3389/fdsfr.2026.1816967The cutaneous mirror: leveraging drug-induced skin phenotypes as early visual risk signals for systemic toxicity, a comprehensive review
Hind B. Alshalhoob, Lama M. Albelowi, Aseel S. Alotaibi, Shada Khalid Alanazi et al.
2026-06-11 · DOI: 10.3389/fdsfr.2026.1825005Methodological comparisons for benefit-risk assessment in complex decision-making: applications and insights from a case study
Jian-Yu E, Kexin Zhu, Stéphanie Tcherny-Lessenot, Juhaeri Juhaeri et al.
2026-06-10 · DOI: 10.3389/fdsfr.2026.1792441Comprehensive pharmacovigilance assessment of pairwise drug–drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugs
Issei Kazume, Kenji Onda, Sachiko Tanaka, Takashi Yokokawa et al.
2026-06-10 · DOI: 10.3389/fdsfr.2026.1827098Evaluating the implementation of intermittent versus continuous fetal heart rate monitoring on intrapartum care and early neonatal outcomes using causal mediational modeling
Omkar Basnet, Rejina Gurung, Pratiksha Bhattarai, Merlind Maria Hofert et al.
2026-06-09 · DOI: 10.3389/fdsfr.2026.1755487Modafinil and abnormal bleeding in a young lady with narcolepsy: a case report
Albatol N. Rashed, Ahmed Abdelbasit, Mana Alshahrani
2026-06-08 · DOI: 10.3389/fdsfr.2026.1767644Strengthening pharmacovigilance and regulatory capacity in Southern Africa (SPaRCS): achievements, experiences and lessons learned from a participatory action learning project
Michelle Viljoen, Star Khoza, Mukesh Dheda, Libert Chirinda et al.
2026-05-29 · DOI: 10.3389/fdsfr.2026.1765077Outcomes of post-approval non-interventional safety studies in pregnancy: wide variation demonstrates need for further standardization
Stacy Chen, Sarah C. MacDonald
2026-05-11 · DOI: 10.3389/fdsfr.2026.1805759Colistin use and outcomes in Kuwait public hospitals
Sarah S. Alghanem, Wadha A. Alfouzan, Moetaza M. Soliman, Ebtehal Alroomi et al.
2026-05-08 · DOI: 10.3389/fdsfr.2026.1808461Global pharmacovigilance reporting: comparative analysis of adverse event obligations across five major regulatory authorities
Carlos G. Bernaus, Maria Lilia Bournissen
2026-05-07 · DOI: 10.3389/fdsfr.2026.1821686Editorial: Pandemic preparedness in vaccine safety and regulation
Manal M. Younus, Florence van Hunsel
2026-04-14 · DOI: 10.3389/fdsfr.2026.1824880Reviews
Community Reviews
Version History
October 2, 2026 at 9:04 pm
October 2, 2026